Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation sensor as 50% smaller than the G7, with a thinner, lower-circumference form ...

Beta Bionics today filed a prospectus outlining its aim to bring in $114.4 million in its initial public offering (IPO).

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

Dexcom (Nasdaq:DXCM) announced that it entered into a new partnership with Life Time Inc., an operator of athletic country clubs.

The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Micron Biomedical announced today that it added $16 million in funding to bring its Series A equity round to more than $33 ...

Analysts called a stock sell-off at Embecta "unwarranted" and believe the company is moving in the right direction despite recent challenges.

Aerogen announced today that it plans to invest about $308.5 million (€300 million) to expand operations in Ireland.